Company news
Alembic Limited news in 2021
Alembic Limited's news releases, calls and decks from 2021, newest first.
Alembic: Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Final Approval for Metronidazole Gel USP. 1%
September 7, 2021
Alembic: Pharmaceuticals announces USFDA Final Approval for Desipramine Hydrochloride Tablets USP, 10 mg. 25 mg. 50 mg, 75 mg, 100 mg, and 150 mg
July 9, 2021
Alembic: Pharmaceuticals announces its joint venture Aleor Dermaceuticals receives USFDA Tentative Approval for Metronidazole Gel USP, 1%.
May 5, 2021
Alembic: Pharmaceuticals announces its wholly-owned subsidiary, Alembic Global Holding SA receives USFDA Final Approval for Treprostinil Injection
February 15, 2021